| scholarly article | Q13442814 |
| P2093 | author name string | M B Orringer | |
| B Marshall | |||
| M D Iannettoni | |||
| P2860 | cites work | Occult cervical nodal metastasis in esophageal cancer: preliminary results of three-field lymphadenectomy | Q73177025 |
| En bloc esophagectomy improves survival for stage III esophageal cancer | Q74063064 | ||
| Strategies to reduce pulmonary complications after transhiatal esophagectomy | Q74571852 | ||
| Extended lymph-node dissection for gastric cancer | Q74629358 | ||
| Detection of micrometastases in histologically negative lymph nodes in esophageal cancer | Q77754627 | ||
| Surgical therapy of oesophageal carcinoma | Q37950431 | ||
| Transhiatal and Transthoracic Esophagectomy for Adenocarcinoma of the Esophagus | Q38533382 | ||
| Selecting the surgical approach to cancer of the esophagus | Q40891658 | ||
| Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer | Q40921687 | ||
| Complications of transhiatal esophagectomy | Q41552693 | ||
| Long-term results of transhiatal esophagectomy for esophageal carcinoma. A multivariate analysis of prognostic factors | Q44047775 | ||
| Comparison of outcomes following transhiatal or Ivor Lewis esophagectomy for esophageal carcinoma | Q44070599 | ||
| Impact of transhiatal esophagectomy on cardiac and respiratory function | Q46076197 | ||
| Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. | Q46682264 | ||
| Early dilation in the treatment of esophageal disruption. | Q52495041 | ||
| Complications of transhiatal esophagectomy. | Q54021231 | ||
| Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus | Q57702493 | ||
| Esophagectomy without thoracotomy. | Q64890462 | ||
| Transhiatal and transthoracic esophagectomy: a comparative study | Q67581918 | ||
| Aggressive treatment of chylothorax complicating transhiatal esophagectomy without thoracotomy | Q67943075 | ||
| Transhiatal esophagectomy for benign and malignant disease | Q70552288 | ||
| Technical aids in performing transhiatal esophagectomy without thoracotomy | Q70579993 | ||
| Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report | Q70736020 | ||
| A comparison of multimodal therapy and surgery for esophageal adenocarcinoma | Q71164736 | ||
| Partial median sternotomy: anterior approach to the upper thoracic esophagus | Q71252525 | ||
| Catastrophic complications of the cervical esophagogastric anastomosis | Q71519146 | ||
| Esophagectomy without thoracotomy: a dangerous operation? | Q71728950 | ||
| Surgical management of esophageal cancer. A decade of change | Q72425025 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 392-400; discussion 400-3 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Transhiatal esophagectomy: clinical experience and refinements | |
| P478 | volume | 230 |
| Q35143202 | A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer |
| Q34593949 | A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer |
| Q35104753 | Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal |
| Q73554414 | Analysis of reduced death and complication rates after esophageal resection |
| Q48703876 | Assisted laparoscopic transhiatal esophagectomy for the treatment of esophageal cancer |
| Q35113474 | Barrett's esophagus: an update |
| Q34120201 | Biologic and clinical significance of lymphadenectomy |
| Q47371915 | Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis |
| Q35552437 | Challenges in reversing esophageal discontinuity operations |
| Q34619328 | Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region |
| Q24197524 | Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer |
| Q38614101 | Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. |
| Q38109512 | Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis |
| Q34993265 | Combined modality therapy of esophageal cancer--standard of care? |
| Q84630027 | Combined pretherapeutic endoscopic and laparoscopic ultrasonography may predict survival of patients with upper gastrointestinal tract cancer |
| Q79633215 | Comparison of the outcomes between open and minimally invasive esophagectomy |
| Q37781543 | Complication following gastric pull-up reconstruction for advanced hypopharyngeal or cervical esophageal carcinoma: a 20-year review in a Chinese institute |
| Q33748312 | Complications of Esophageal Surgery: Role of Imaging in Diagnosis and Treatments |
| Q94332150 | Conference Abstracts from the 2006 Annual Meeting of the International Society of Gastrointestinal Oncology: Session 1: Esophageal Cancer |
| Q74591731 | Controversies in the current therapy of carcinoma of the esophagus |
| Q37076597 | Crossroads in the combined-modality management of gastroesophageal junction carcinomas. |
| Q50050226 | Current concepts in the management of leakages after esophagectomy |
| Q81368416 | Current management of esophageal cancer |
| Q34048027 | Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer |
| Q51724179 | Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. |
| Q73388258 | Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis |
| Q38284597 | Emerging mAbs for the treatment of esophagogastric cancer |
| Q38110962 | Emerging tyrosine kinase inhibitors for esophageal cancer |
| Q39327490 | Endoscopic and symptomatic assessment of anastomotic strictures following esophagectomy and cervical esophagogastrostomy |
| Q86521394 | Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center |
| Q36341280 | Endoscopic therapy for oesophageal cancer. |
| Q35893814 | Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma |
| Q36076031 | Epidermal growth factor receptor expression in esophageal adenocarcinoma: relationship with tumor stage and survival after esophagectomy |
| Q38671121 | Esophageal Cancer: Current Options for Therapeutic Management |
| Q38856216 | Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis. |
| Q34151922 | Esophageal cancer: a systematic review |
| Q84232356 | Esophageal replacement following gastric devascularization is safe, feasible, and may decrease anastomotic complications |
| Q74534938 | Esophagectomy for achalasia: patient selection and clinical experience |
| Q55395345 | Esophagectomy with gastric conduit reconstruction for benign disease: extreme but important. |
| Q44209329 | Esophagectomy without mortality: what can surgeons do? |
| Q37204947 | Esophagectomy without thoracotomy: 25 years of experience over 750 patients |
| Q36306098 | Esophagogastrectomy: the influence of stapled versus hand-sewn anastomosis on outcome |
| Q81484792 | Esophagospinal fistula with spondylodiscitis and meningitis after esophagectomy with gastric pull-up |
| Q26753866 | Evidence-Based Operative Details in Esophageal Cancer Treatment: Surgical Approach, Lymphadenectomy, Anastomosis |
| Q73580486 | Experience and technique of stapled mechanical cervical esophagogastric anastomosis |
| Q36345929 | Experience with minimally invasive esophagectomy |
| Q73682764 | Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy |
| Q43406220 | Factors predictive of complete resection of operable esophageal cancer: a prospective study. |
| Q40393227 | Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus |
| Q37021609 | Fluid administration and morbidity in transhiatal esophagectomy |
| Q36407022 | Fluoroscopically guided nose tube drainage of mediastinal abscesses in post-operative gastro-oesophageal anastomotic leakage |
| Q35830588 | Fluoroscopically guided three-tube insertion for the treatment of postoperative gastroesophageal anastomotic leakage |
| Q81453547 | Fundus rotation gastroplasty vs. Kirschner-Akiyama gastric tube in esophageal resection: comparison of perioperative and long-term results |
| Q45346900 | Gangrene of the oesophago-gastric junction caused by strangulated hiatal hernia: operative challenge or surgical dead end. |
| Q85713987 | Gastric ischemic conditioning increases neovascularization and reduces inflammation and fibrosis during gastroesophageal anastomotic healing |
| Q34153314 | Gastric transposition for esophageal replacement in children: experience with 41 consecutive cases with special emphasis on esophageal atresia |
| Q38443481 | Hand-sewn vs linearly stapled esophagogastric anastomosis for esophageal cancer: a meta-analysis |
| Q50469546 | Hemodynamics of the reconstructed gastric tube during esophagectomy: assessment of outcomes with indocyanine green fluorescence. |
| Q38725350 | High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma |
| Q58484706 | Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World |
| Q81624678 | Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy |
| Q74408238 | Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland |
| Q87060396 | Hybrid trans-thoracic esophagectomy with side-to-side stapled intra-thoracic esophagogastric anastomosis for esophageal cancer |
| Q36345936 | Immediate preoperative laparoscopic staging for squamous cell carcinoma of the esophagus |
| Q43545856 | Improved prognosis of resected esophageal cancer |
| Q79782670 | Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection |
| Q43486615 | Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy |
| Q39159138 | Indications for Direct Laryngoscopic Examination of Vocal Cord Function Prior to Anterior Cervical Surgery |
| Q44133406 | Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer |
| Q36155072 | Individualised surgical treatment of patients with an adenocarcinoma of the distal oesophagus or gastro-oesophageal junction |
| Q35517168 | Initial clinical outcomes after completion of training in a Canadian Royal College thoracic surgery program. |
| Q47851545 | Intraperitoneal photodynamic therapy causes a capillary-leak syndrome |
| Q36246281 | Intrathoracic leaks following esophagectomy are no longer associated with increased mortality |
| Q35208672 | Is neoadjuvant therapy the answer to adenocarcinoma of the esophagus? |
| Q42642300 | Ischemic conditioning shows a time-dependant influence on the fate of the gastric conduit after minimally invasive esophagectomy |
| Q74099142 | Ivor Lewis esophagogastrectomy for esophageal cancer |
| Q82635551 | Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit |
| Q47820550 | Laparoscopic esophagectomy in the palliative treatment of advanced esophageal cancer after radiochemotherapy. |
| Q81858106 | Laparoscopic hand-assisted versus open transhiatal esophagectomy: a case-control study |
| Q79633221 | Laparoscopic ischemic conditioning of the stomach for esophageal replacement |
| Q35100465 | Laparoscopic transhiatal esophagectomy at a low-volume center |
| Q30483449 | Laparoscopic transhiatal esophagectomy: outcomes |
| Q52340941 | Laparoscopic-Assisted Transhiatal Esophagectomy (LATE) for Carcinoma of the Esophagus. |
| Q36179887 | Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma |
| Q73235934 | Limited resection for early esophageal cancer? |
| Q51306277 | Linear-Stapled Side-to-Side Esophagojejunostomy with Hand-Sewn Closure of the Common Enterotomy After Prophylactic and Therapeutic Total Gastrectomy. |
| Q84286576 | Lymphadenectomy along the left recurrent laryngeal nerve by a minimally invasive esophagectomy in the prone position for thoracic esophageal cancer |
| Q58774267 | MINIMALLY INVASIVE LAPAROSCOPIC ESOPHAGECTOMY VS. TRANSHIATAL OPEN ESOPHAGECTOMY IN ACHALASIA: A RANDOMIZED STUDY |
| Q40340727 | Management of intrathoracic leakage after radical total gastrectomy |
| Q36680835 | Management of intrathoracic leaks following esophagectomy |
| Q36262306 | Management of oesophageal cancer |
| Q38216030 | Managing complications II: conduit failure and conduit airway fistulas |
| Q75306071 | Mediastinoscope-assisted transhiatal esophagectomy for esophageal cancer |
| Q35909256 | Mediastinoscopic esophagectomy for patients with early esophageal cancer |
| Q82433807 | Mediastinoscopy-assisted esophagectomy for esophageal cancer in patients with serious comorbidities |
| Q38926586 | Minimally Invasive Esophagectomy: Is There an Advantage? |
| Q79931436 | Minimally invasive esophagectomy for cancer: prospective evaluation of laparoscopic gastric mobilization |
| Q53903821 | Minimally invasive esophagectomy. |
| Q42610353 | Minimally invasive esophagectomy: outcomes in 222 patients. |
| Q50162013 | Minimally invasive esophagectomy: the evolution and technique of minimally invasive surgery for esophageal cancer |
| Q38306794 | Minimally invasive oesophagectomy in prone versus lateral decubitus position: A comparative study |
| Q33622016 | Minimally invasive surgery and cancer: controversies part 1. |
| Q50695947 | Minimally invasive transhiatal esophagectomy: lessons learned. |
| Q33534720 | Minimally invasive versus open esophagectomy: meta-analysis of outcomes |
| Q74402501 | Minimizing cervical esophageal anastomotic complications by a modified technique |
| Q46723357 | Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). |
| Q38067386 | Multidisciplinary approach for patients with esophageal cancer |
| Q38060114 | Multimodality approach for locally advanced esophageal cancer |
| Q37338260 | Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction |
| Q36450765 | Multimodality treatment of esophageal cancer: a review of the current status and future directions |
| Q41099878 | Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy |
| Q37559802 | Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma |
| Q24799989 | Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline |
| Q24797571 | Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis |
| Q38097674 | Neoadjuvant or adjuvant therapy for resectable esophageal cancer: is there a standard of care? |
| Q34063710 | Neoadjuvant treatment of esophageal cancer |
| Q36980794 | Non-operative management of small cell carcinoma of esophagus |
| Q34325751 | Oesophageal carcinoma |
| Q38599587 | Operative and survival outcomes in a series of 100 consecutive cases of robot-assisted transhiatal esophagectomies |
| Q37967701 | Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions |
| Q44284360 | Outcomes after esophagectomy: a ten-year prospective cohort |
| Q33920466 | Outcomes after minimally invasive esophagectomy: review of over 1000 patients |
| Q37076550 | Outcomes after surgery for esophageal cancer |
| Q38242093 | Outcomes in the management of esophageal cancer |
| Q34488764 | Outcomes of Patients With Esophageal Cancer Staged With [18F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection? |
| Q51600862 | PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma. |
| Q79166016 | Patients surviving 5 years after curative oesophagectomy for oesophageal cancer |
| Q35199178 | Pattern of lymphatic spread of Barrett's cancer |
| Q36666653 | Perioperative outcomes associated with robotic Ivor Lewis esophagectomy in patient's undergoing neoadjuvant chemoradiotherapy |
| Q43219626 | Persistent air-leak after transhiatal oesophagectomy: A case report |
| Q43038423 | Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer |
| Q36198144 | Postesophagectomy chylothorax: incidence, risk factors, and outcomes |
| Q51710586 | Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy. |
| Q81417060 | Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation |
| Q45249978 | Pre-therapy laparoscopic feeding jejunostomy is safe and effective in patients undergoing minimally invasive esophagectomy for cancer |
| Q33587884 | Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer |
| Q73322818 | Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection |
| Q34133427 | Proposed follow up programme after curative resection for lower third oesophageal cancer |
| Q38116622 | Radical lymphadenectomy in esophageal cancer: from the past to the present |
| Q57247829 | Randomized Trial Comparing Side-to-Side Stapled and Hand-Sewn Esophagogastric Anastomosis in Neck |
| Q38352330 | Readmission and risk factors for readmission following esophagectomy for esophageal cancer |
| Q50724171 | Release of band cells from the bone marrow is impaired by preoperative chemoradiation in patients with esophageal carcinoma: increased risk of postoperative pneumonia. |
| Q33989853 | Reliable management of post-esophagectomy anastomotic fistula with endoscopic trans-fistula negative pressure drainage |
| Q36165147 | Review of minimally invasive esophagectomy and current controversies |
| Q37797980 | Review of open and minimal access approaches to oesophagectomy for cancer |
| Q46218180 | Risk prediction scores for postoperative mortality after esophagectomy: validation of different models. |
| Q42639032 | Robot-assisted transhiatal esophagectomy: a 3-year single-center experience |
| Q36972508 | Robotically assisted laparoscopic transhiatal esophagectomy |
| Q35168047 | Section VI: complications following esophagectomy: early detection, treatment, and prevention |
| Q77089925 | Should en bloc esophagectomy be the standard of care for esophageal carcinoma? |
| Q74072043 | Skeletonizing en bloc esophagectomy for cancer |
| Q41543421 | Stapled versus hand-sewn cervical esophagogastric anastomosis in patients undergoing esophagectomy: A Retrospective Cohort Study |
| Q34979159 | Successful closure of a postsurgical benign esophagomediastinal fistula by temporary placement of a polyester, expandable stent: Case report and review. |
| Q35847046 | Successful treatment of esophageal cancer with transhiatal esophagectomy after heart transplantation |
| Q35122545 | Surgical management of esophageal malignancy |
| Q34749512 | Surgical treatment of esophageal adenocarcinoma: concepts in evolution |
| Q36531698 | Surgical treatment of superficial esophageal cancer |
| Q43797004 | Systemic inflammatory response syndrome as a predictor of anastomotic leakage after esophagectomy |
| Q37836513 | Targeted therapies for metastatic esophagogastric cancer |
| Q36039645 | Targeted therapy for esophagogastric cancers: a review |
| Q34993251 | Technique and role of minimally invasive esophagectomy for premalignant and malignant diseases of the esophagus |
| Q37759767 | The "best operation" for esophageal cancer? |
| Q38795527 | The Predictive Value of Coefficient of PCT × BG for Anastomotic Leak in Esophageal Carcinoma Patients With ARDS After Esophagectomy |
| Q36986846 | The current management of esophageal cancer |
| Q39211707 | The resection of the azygos vein--necessary or redundant extension of transthoracic esophagectomy? |
| Q36620349 | The role of one-year endoscopic follow-up for the esophageal remnant and gastric conduit after esophagectomy with gastric reconstruction for esophageal squamous cell carcinoma |
| Q35193680 | The role of surgery in the management of oesophageal cancer |
| Q80218919 | The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation |
| Q51382343 | Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy. |
| Q28077519 | Three-field lymph node dissection in treating the esophageal cancer |
| Q38165882 | Three-field transthoracic versus transhiatal esophagectomy in the management of carcinoma esophagus-a single--center experience with a review of literature |
| Q74194506 | To stent or not to stent? |
| Q37471557 | Total oesophagectomy for squamous cell carcinoma with or without standard two field node dissection - a prospective study |
| Q38188904 | Tracheobronchial injury in the setting of an esophagectomy for cancer: postoperative discovery a bad omen |
| Q51707707 | Transhiatal esophagectomy for benign and malignant conditions. |
| Q34241866 | Transhiatal esophagectomy for treatment of benign and malignant esophageal disease |
| Q21093263 | Transhiatal esophagectomy in a high volume institution |
| Q83098470 | Transhiatal oesophagectomy: techniques, tips and outcomes |
| Q46689071 | Transthoracic and transhiatal esophagectomy using minimally invasive techniques. Experience in 50 patients |
| Q77485065 | Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma |
| Q34993261 | Transthoracic or transhiatal esophagectomy for cancer of the esophagus--does it matter? |
| Q81492389 | Transthoracic or transhiatal resection for middle- and lower-third esophageal carcinoma? |
| Q74241101 | Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis |
| Q41555284 | Treatment of anastomotic leaks with metallic stent after esophagectomies |
| Q51597078 | Treatment of thoracic anastomotic leaks after esophagectomy with self-expanding plastic stents. |
| Q36918601 | Two thousand transhiatal esophagectomies: changing trends, lessons learned. |
| Q34366123 | Two-field dissection is enough for esophageal cancer |
| Q36485831 | Updates on esophageal and gastric cancers |
| Q34688528 | Use of minimally invasive oesophagectomy for cancer of the oesophagus |
| Q53741724 | Usefulness of Pyloromyotomy With Transhiatal Esophagectomy in Improving Gastric Emptying. |
| Q41992696 | Usefulness of indocyanine green angiography for evaluation of blood supply in a reconstructed gastric tube during esophagectomy |
| Q46161369 | Vagal-sparing esophagectomy: a more physiologic alternative |
| Q79854380 | Validation of the functional assessment of cancer therapy esophageal cancer subscale |
| Q53395748 | Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. |
| Q82973275 | [Anastomoses in the upper gastrointestinal tract] |
| Q82921022 | [Complications following oesophagectomy: mechanism, detection, treatment and prevention] |
| Q82296217 | [Laparoscopic surgery in cancer of the esophagus] |
| Q80217754 | [Preoperative colonoscopy before esophagectomy and reconstruction with gastric interposition] |
| Q82862681 | [Therapy management of chylothorax] |
Search more.